IVW vs XBI

iShares S&P 500 Growth ETF vs SPDR S&P Biotech ETF

Quick take
  • • IVW has the lower expense ratio at 0.18% vs 0.35% for XBI.
  • • IVW pays a higher dividend yield (0.36%).

Side-by-side metrics

MetricIVWXBI
Expense ratio
Annual fee. Lower is better.
0.18%0.35%
Dividend yield
Trailing 12-month yield.
0.36%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$74.73B$10.92B
YTD return
8.25%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.181.01
P/E ratio
26.67—
Last price
$134.95$156.41
Inception
——
Issuer
iSharesState Street

IVW top holdings

Top holdings · IVW
NVDANVIDIA Corp14.19%
MSFTMicrosoft Corp11.11%
AAPLApple Inc7.21%
GOOGLAlphabet Inc Class A4.71%
AVGOBroadcom Inc4.45%
METAMeta Platforms Inc Class A3.89%
GOOGAlphabet Inc Class C3.79%
AMZNAmazon.com Inc3.58%
LLYEli Lilly and Co3.25%
BRK-BBerkshire Hathaway Inc Class B2.90%
Sector breakdown · IVW
Real Estate0.6%
Consumer Cyclical8.6%
Basic Materials0.3%
Consumer Defensive1.2%
Technology53.3%
Communication Services13.5%
Financial Services9.5%
Utilities0.3%
Industrials5.3%
Healthcare7.3%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About IVW

IVW (iShares S&P 500 Growth ETF) is S&P 500 growth subset. Managed by iShares, the fund carries $74.7B in assets under management, an expense ratio of 0.18%, a dividend yield of 0.36%. Its largest holding is NVIDIA Corp (NVDA), which represents 14.2% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.